Shelton Wealth Management »

Halozyme Therapeutics shares owned by Shelton Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Shelton Wealth Management from 13F filings

Historical chart of Shelton Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Shelton Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Shelton Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $997k 17k 57.24
2024-06-30 $918k 18k 52.36
2024-03-31 $734k 18k 40.68

More positions owned by Shelton Wealth Management

Amazon Call Option (AMZN)
First Tr Exchange-traded First Tr Enh New (FTSM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Rus Mid Cap Etf (IWR)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Rus 1000 Etf (IWB)
Advanced Micro Devices Call Option (AMD)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Ibonds 29 Trm Ts (IBTJ)
Ishares Tr Ibonds 28 Trm Ts (IBTI)
Ishares Tr Ibonds 27 Trm Ts (IBTH)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Ibonds 25 Trm Ts (IBTF)
First Tr Exchange Trad Fd Vi FST TR GLB FD (FTGC)

View all positions for Shelton Wealth Management

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics